SynthesisClinical drug investigation2014

Bevacizumab increases the risk of severe congestive heart failure in cancer patients: an up-to-date meta-analysis with a focus on different subgroups.

Wei-Xiang Qi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.